Abstract
BackgroundPatients with Antiphospholipid Syndrome (APS) carry an increased burden of cardiovascular morbidity and mortality and have higher prevalence of traditional cardiovascular risk factors (CVRFs) and subclinical atherosclerosis [1]. Arterial stiffness...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
